These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21804249)

  • 1. Synthesis and pharmacological evaluation of 1-isopropyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel antihypertensive agents.
    Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
    Chem Pharm Bull (Tokyo); 2011; 59(8):1029-37. PubMed ID: 21804249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of 1-alkyl-N-[(1R)-1-(4-fluorophenyl)-2-methylpropyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents.
    Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
    Chem Pharm Bull (Tokyo); 2011; 59(11):1376-85. PubMed ID: 22041074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents.
    Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2011 Sep; 19(18):5628-38. PubMed ID: 21875808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and pharmacological evaluation of 2-(1-alkylpiperidin-4-yl)-n-[(1r)-1-(4-fluorophenyl)-2-methylpropyl]acetamide Derivatives as Novel Antihypertensive Agents.
    Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
    Chem Pharm Bull (Tokyo); 2012; 60(2):223-34. PubMed ID: 22293482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of 1-oxo-2-(3-piperidyl)-1,2,3,4- tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing I(f) channel inhibitory activity.
    Kubota H; Kakefuda A; Watanabe T; Ishii N; Wada K; Masuda N; Sakamoto S; Tsukamoto S
    J Med Chem; 2003 Oct; 46(22):4728-40. PubMed ID: 14561092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of 2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinoline derivatives as specific bradycardic agents.
    Kakefuda A; Watanabe T; Taguchi Y; Masuda N; Tanaka A; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):390-8. PubMed ID: 12672990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
    Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2004 Mar; 12(5):871-82. PubMed ID: 14980599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive effect of some oxazolo[3,2-a]pyridines, thiazolo[3,2-a]pyridines and pyrido[2,1-b]oxazines in conscious spontaneously hypertensive rats.
    Moran A; Martín E; Velasco C; Martín ML; San Roman L; Caballero E; Puebla P; Medarde M; San Feliciano A
    J Pharm Pharmacol; 1997 Apr; 49(4):421-5. PubMed ID: 9232541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
    Shanklin JR; Johnson CP; Proakis AG; Barrett RJ
    J Med Chem; 1991 Oct; 34(10):3011-22. PubMed ID: 1920352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasodilation and Antihypertensive Activities of Swietenia macrophylla (Mahogany) Seed Extract.
    Ch'ng YS; Loh YC; Tan CS; Ahmad M; Asmawi MZ; Wan Omar WM; Yam MF
    J Med Food; 2018 Mar; 21(3):289-301. PubMed ID: 29420109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyrimidine calcium channel blockers. 4. Basic 3-substituted-4-aryl-1,4-dihydropyrimidine-5-carboxylic acid esters. Potent antihypertensive agents.
    Rovnyak GC; Atwal KS; Hedberg A; Kimball SD; Moreland S; Gougoutas JZ; O'Reilly BC; Schwartz J; Malley MF
    J Med Chem; 1992 Aug; 35(17):3254-63. PubMed ID: 1387168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benzazepinone calcium channel blockers. 2. Structure-activity and drug metabolism studies leading to potent antihypertensive agents. Comparison with benzothiazepinones.
    Floyd DM; Kimball SD; Krapcho J; Das J; Turk CF; Moquin RV; Lago MW; Duff KJ; Lee VG; White RE
    J Med Chem; 1992 Feb; 35(4):756-72. PubMed ID: 1542102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel tetrahydroisoquinoline derivatives as orally active N-type calcium channel blockers with high selectivity for hERG potassium channels.
    Ogiyama T; Inoue M; Honda S; Yamada H; Watanabe T; Gotoh T; Kiso T; Koakutsu A; Kakimoto S; Shishikura J
    Bioorg Med Chem; 2014 Dec; 22(24):6899-907. PubMed ID: 25456079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihypertensive effects of lercanidipine in experimental hypertensive rats and dogs.
    Sironi G; Montagna E; Greto L; Bianchi G; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Feb; 46(2):145-52. PubMed ID: 8720303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T- and L-type calcium channel blocker (CCB) mibefradil attenuates leg edema induced by the L-type CCB nifedipine in the spontaneously hypertensive rat: a novel differentiating assay.
    Major TC; Dhamija S; Black N; Liachenko S; Morenko B; Sobocinski G; Okerberg C; Tinholt P; Madore S; Kowala MC
    J Pharmacol Exp Ther; 2008 Jun; 325(3):723-31. PubMed ID: 18326812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benzazepinone calcium channel blockers. 3. Synthesis and structure-activity studies of 3-alkylbenzazepinones.
    Das J; Floyd DM; Kimball SD; Duff KJ; Vu TC; Lago MW; Moquin RV; Lee VG; Gougoutas JZ; Malley MF
    J Med Chem; 1992 Feb; 35(4):773-80. PubMed ID: 1542103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biosimulation and pharmacological evaluation of benzimidazole derivatives with antihypertensive multitarget effect.
    Gutiérrez-Hernández A; Estrada-Soto S; Martínez-Conde C; Gaona-Tovar E; Medina-Franco JL; Hernández-Núñez E; Hidalgo-Figueroa S; Castro-Moreno P; Ibarra-Barajas M; Navarrete-Vazquez G
    Bioorg Med Chem Lett; 2024 Sep; 110():129879. PubMed ID: 38977106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model.
    Guo H; Wang Y; Cai W; He C
    PLoS One; 2020; 15(4):e0231244. PubMed ID: 32298274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.